News
Higher user fees would increase regulatory barriers to market, added Michael H. Cohen, an FDA attorney in Palo Alto, California, but a shift in the way the FDA regulates digital health could ease ...
Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...
In a letter to Sen. Patty Murray (D-Wash.), Price “strongly urged” lawmakers to include the president’s user fee structure in the reauthorization bill. “To ensure the FDA has the critical ...
The FDA also sent Congress its proposal for the traditional prescription drug user-fee program, which is expected to raise more than $712.8 million in fees annually over five years.
President Donald Trump’s proposal to increase FDA user fees is already drawing some reaction from an industry that wants to cooperate, but is blanching at a proposal that would dramatically ...
The FDA doesn’t appear to be buying the two year compromise on user fees that the medical device industry is floating in lieu of a full reauthorization of the fees med tech companies pay to the ...
Proposal would expand FDA oversight, keep user fees . Haymarket Media. July 20, 2007 . Share ...
The FDA also sent Congress its proposal for the traditional prescription drug user fee program, which is expected to raise more than $712.8 million in fees annually over five years.
FDA says it needs the fees for its medical device review program to keep pace with the growing industry and changes in technology. Under the proposal, which the agency negotiated with the medical ...
Under the proposal from FDA, pharmaceutical companies in fiscal year 2008 would pay the agency about $393 million in user fees, compared with $305 million in FY 2007. FDA would use about $30 million ...
Under the proposal, the user fees for biosimilars ... 2011, and is requesting comments -which are due by January 6, 2011. FDA's proposal can be found at 76 Fed. Reg. 76, 424 ...
On May 10, 2011, the FDA published a Request for Comments on its proposal for setting user fees for 351(k) biosimilar applications: “Biologics Price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results